January 31, 2026
A value-style global equity fund seeking long-term growth.
Is this fund right for you?
- You want your money to grow over the longer term.
- You want to invest in companies anywhere in the world.
- You're comfortable with a moderate level of risk.
RISK RATING
How is the fund invested? (as of September 30, 2025)
| Name | Percent |
|---|---|
| US Equity | 52.7 |
| International Equity | 39.0 |
| Cash and Equivalents | 4.7 |
| Canadian Equity | 3.0 |
| Foreign Bonds | 0.5 |
| Income Trust Units | 0.1 |
| Name | Percent |
|---|---|
| United States | 57.7 |
| United Kingdom | 9.7 |
| Japan | 7.2 |
| Canada | 3.2 |
| France | 2.8 |
| Korea, Republic Of | 2.0 |
| Germany | 1.6 |
| China | 1.5 |
| Taiwan | 1.5 |
| Other | 12.8 |
| Name | Percent |
|---|---|
| Technology | 24.0 |
| Consumer Goods | 15.3 |
| Consumer Services | 10.6 |
| Financial Services | 9.5 |
| Healthcare | 9.3 |
| Industrial Goods | 5.6 |
| Industrial Services | 5.5 |
| Cash and Cash Equivalent | 4.7 |
| Energy | 3.3 |
| Other | 12.2 |
Growth of $10,000 (since inception)
For the period 07/09/2018 through 01/31/2026 tr.with $10,000 CAD investment, The value of the investment would be $19,321
Fund details (as of September 30, 2025)
| Top holdings | Percent (%) |
|---|---|
| NVIDIA Corp | 3.8 |
| Microsoft Corp | 2.1 |
| Meta Platforms Inc Cl A | 1.9 |
| Amazon.com Inc | 1.5 |
| Imperial Brands PLC | 1.3 |
| Broadcom Inc | 1.2 |
| Alphabet Inc Cl C | 1.2 |
| British American Tobacco PLC | 1.2 |
| Apple Inc | 1.1 |
| Roku Inc Cl A | 0.8 |
| Total allocation in top holdings | 16.1 |
| Portfolio characteristics | Value |
|---|---|
| Standard deviation | 8.21% |
| Dividend yield | 2.09% |
| Yield to maturity | - |
| Duration (years) | - |
| Coupon | - |
| Average credit rating | Not rated |
| Average market cap (million) | $741,960.7 |
Understanding returns
Annual compound returns (%)
| 1 MO | 3 MO | YTD | 1 YR |
|---|---|---|---|
| 1.70 | 6.39 | 1.70 | 10.80 |
| 3 YR | 5 YR | 10 YR | INCEPTION |
|---|---|---|---|
| 15.65 | 10.07 | - | 9.10 |
Calendar year returns (%)
| 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|
| 13.24 | 21.25 | 14.70 | -6.26 |
| 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|
| 8.04 | 20.20 | 5.18 | - |
Range of returns over five years (August 01, 2018 - January 31, 2026)
| Best return | Best period end date | Worst return | Worst period end date |
|---|---|---|---|
| 14.24% | Mar 2025 | 5.84% | Sep 2023 |
| Average return | % of periods with positive returns | Number of positive periods | Number of negative periods |
|---|---|---|---|
| 10.19% | 100 | 31 | 0 |
Q4 2025 Fund Commentary
Commentary and opinions are provided by Fidelity Investments Canada ULC.
Market commentary
Global equity markets rose in the fourth quarter of 2025, with the MSCI ACWI returning 1.8% (in Canadian-dollar terms). Global investment-grade bonds, represented by the Bloomberg Global Aggregate Bond Index, fell 1.2% (in Canadian-dollar terms). International markets outpaced U.S. markets, and value-tilted segments showed strength. Corporate earnings momentum held, and monetary policy expectations supported markets.
In the U.S., inflation rose to 2.7% on a year-over-year basis in November, and the U.S. economy grew at an annualized rate of 4.3%, the strongest pace in two years. Growth was driven by consumer spending, rebounding exports and government spending. The U.S. unemployment rate remained elevated, rising to 4.6% in November. On trade, headlines turned incrementally supportive as the U.S. and China announced a one-year trade truce. The U.S. Federal Reserve Board cut the range of its federal funds rate, ending December at 3.50%–3.75%.
Against this backdrop, eight of the 11 MSCI ACWI sectors rose, led by the health care, materials and financials sectors. The real estate, consumer discretionary and consumer staples sectors lagged.
Performance
The Fund’s relative exposures to Alphabet Inc., Eli Lilly and Co. and Micron Technology Inc. contributed to performance. Alphabet posted better-than-expected revenue growth because of advertising and business driven by artificial intelligence (AI). Eli Lilly’s performance was driven by strong demand for its weight-loss drugs, Mounjaro and Zepbound. Micron Technology shares rose because of rising demand for high-bandwidth memory tied to AI data centre growth.
Relative exposures to Meta Platforms Inc., Microsoft Corp. and Oracle Corp. detracted from the Fund’s performance. Meta Platforms was affected by investor expectations for higher expenditures in AI infrastructure, data centres, microchips and server expansion, which led the company’s shares to fall. Microsoft’s stock fell because of AI spending on infrastructure for foundational models. Similarly, Oracle was impacted by reliance on debt to finance AI data centre expansion.
At a sector level, exposures to the health care and information technology sectors contributed to the Fund’s performance. Exposures to the consumer discretionary and communication services sectors detracted from performance.
At a regional level, exposures to Europe and the U.S. contributed to the Fund’s performance. Exposure to Asia (excluding Japan) detracted from performance.
Portfolio activity
There were no notable transactions made in the Fund during the period.
Outlook
The sub-advisor is focused on capital preservation, selecting securities with appealing risk-reward profiles that should be less affected by the current macroeconomic uncertainty. According to the sub-advisor, opportunities often arise during periods of market volatility. From a growth perspective, the sub-advisor aims for long-term capital growth by taking advantage of uncertainty.
The sub-advisor believes that we’re in a stock-picking environment and stresses the importance of diversification. The sub-advisor recently capitalized on market volatility to invest in AI and connected TV, believing in their strong growth potential.